Mesothelioma metastasis occurs when the cancer forms new tumors in other parts of your body. It often means there has been a serious progression of the disease. A new clinical trial, A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies, will study whether a new immunotherapy drug can slow or reverse mesothelioma metastasis. The study is open to patients with more than a dozen forms of cancer, showing the promise of immunotherapy to reorganize the way cancer is treated. The effectiveness of many immunotherapy treatments may depend more on the way your cancer hides … [Read more...]
Clinical Trials
Clinical Trial of Olaparib for Mesothelioma
The National Cancer Institute (NCI) will soon begin to recruit patients for a study of treatment with olaparib for mesothelioma. The two-year Phase II clinical trial (identifier NCT03531840) will examine whether a drug that is approved for treatment of advanced ovarian cancer and breast cancer can also prevent tumor progression in mesothelioma patients. Olaparib is produced by AstraZeneca and is also known by its trade name, LYNPARZA. The potential usefulness of olaparib for mesothelioma comes down to genetic factors that may predispose some patients to certain cancers. Olaparib is … [Read more...]
Immunotherapy Clinical Trial Produces Revolutionary Results
Scientists are known for being cautious. They validate their results before going public with their research. They are wary of making promises they can’t keep. So you know that, when Laszlo G. Radvanyi of the Ontario Institute for Cancer Research calls immunotherapy clinical trial results “unprecedented” and states that this may lead to a “revolution” in cancer treatment, the research has found something big. The immunotherapy clinical trial results that got Dr. Radvanyi excited were for just one patient. Her recovery from late-stage metastatic breast cancer was so dramatic that researchers … [Read more...]
Mesothelioma Clinical Trial Studies Effectiveness of Multimodal Treatment
At the 14th International Conference of the International Mesothelioma Interest Group (iMig) held in Ottawa, Canada early this month, researchers presented the results of both ongoing and completed research; there was a mesothelioma clinical trial on almost every issue relating to mesothelioma treatment and care. One mesothelioma clinical trial featured at the conference is an effort to compile data on best practices for multimodal mesothelioma treatment. This mesothelioma clinical trial received an iMig 2018 Young Investigators Award, a program sponsored by Kazan Law. This clinical trial … [Read more...]
Mesothelioma Clinical Trial Explores Targeted Radiotherapy
Radiation treatment is one of the three primary mesothelioma treatments (the other two are chemotherapy and surgery). Radiation can be effective at reducing the size of mesothelioma tumors, especially in conjunction with chemotherapy. But, like the other standard mesothelioma treatments, radiotherapy has its limits. A new mesothelioma clinical trial will explore a method to make mesothelioma radiation treatment much more effective. Mesothelioma Clinical Trial Tests Injected Radiation Treatment The new mesothelioma clinical trial started recruiting patients at the end of April, 2018. The … [Read more...]
How to Decide if a Mesothelioma Clinical Trial is Right for You
If you’ve been diagnosed with mesothelioma, you might want to consider enrolling in a mesothelioma clinical trial. With a number of new mesothelioma immunotherapy treatments in the pipeline, there are more studies underway than ever. This means more opportunities for mesothelioma patients to get an early shot at cutting-edge therapies. A mesothelioma clinical trial can benefit you in several ways, including: You have the opportunity to try a new mesothelioma treatment. If that treatment is successful, you will be one of the first to benefit from it. The researchers who lead clinical … [Read more...]
New Mesothelioma Clinical Trial Recruiting Malignant Pleural or Peritoneal Mesothelioma Patients
Each new mesothelioma clinical trial places one more piece in the puzzle of mesothelioma treatment. But sometimes, a mesothelioma clinical trial will add a whole new dimension to the puzzle with new pieces waiting to be filled in. That’s what happened when scientists studied a new drug, LMB-100. Recent trials of a lab-created protein called LMB-100 uncovered two facts about this potential mesothelioma immunotherapy treatment: it worked well for some patients but not at all for others. In those patients, researchers found, the drug stimulated an immune response that neutralized its … [Read more...]
New Mesothelioma Clinical Trial Recruiting Patients
Mesothelioma clinical trials are the forefront of the development of new mesothelioma treatments. Mesothelioma patients first got the opportunity to try immunotherapy treatments during mesothelioma clinical trials. Based on promising results for some patients with mesothelioma and other hard-to-treat cancers, immunotherapy has now become available to a wider cohort of patients. A mesothelioma clinical trial is an option that patients and their families should research and consider. Clinical trial NCT02637531 explores a new and promising treatment for cancer patients with advanced tumors. … [Read more...]
Mesothelioma Immunotherapy Clinical Trials Target Mesothelin Protein
Mesothelioma immunotherapy treatments are producing good results for some mesothelioma patients and offering hope for many more. Research into new and better mesothelioma immunotherapy protocols is ongoing; there are a large number of clinical trials underway, with the promise of new treatments for mesothelioma patients. Several recent studies have focused attention on a tumor antigen called mesothelin that is found in mesothelioma and several other types of cancerous tumors. What is Mesothelin? Mesothelin is a protein found in the genes of your mesothelial tissues. Mesothelium are the … [Read more...]
Cancer Clinical Trials Lacking Qualified Patients
Recent medical breakthroughs have led to a host of new cancer drugs coming to market. Many of these offer hope for patients with cancers that are rare or hard to treat, such as mesothelioma. As a result, there are many more cancer clinical trials underway at once than is usually the case. Despite the increasing prevalence of cancer, this research boom has led to a shortage of qualified participants. Many of the current cancer clinical trials test the effectiveness of immunotherapy drugs and other experimental cancer treatments. Some cancer patients, including some mesothelioma patients, … [Read more...]
- 1
- 2
- 3
- 4
- Next Page »